Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704

PURPOSE: NRG Oncology RTOG 9704 was the first adjuvant trial to validate the prognostic value of postresection CA19-9 levels for survival in patients with pancreatic carcinoma. The data resulting from this study also provide information about predictors of recurrence that may be used to tailor indiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Radiat Oncol
Main Authors: Regine, William F., Winter, Kathryn, Abrams, Ross A., Safran, Howard, Kessel, Ivan L., Chen, Yuhchyau, Fugazzi, James A., Donnelly, Eric D., DiPetrillo, Thomas A., Narayan, Samir, Plastaras, John P., Gaur, Rakesh, Delouya, Guila, Suh, John H., Meyer, Joshua E., Haddock, Michael G., Didolkar, Mukund S., Padula, Gilbert D.A., Johnson, David, Hoffman, John P., Crane, Christopher H.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Pancreas Tumor
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000159/
https://ncbi.nlm.nih.gov/pubmed/29904740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2018.01.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados